- Home
- RVPHW vs GDST Comparison
RVPHW vs GDST Comparison
Compare RVPHW & GDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- GDST
- Stock Information
- Founded
- RVPHW N/A
- GDST 2020
- Country
- RVPHW United States
- GDST United States
- Employees
- RVPHW 15
- GDST N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- GDST
- Sector
- RVPHW Health Care
- GDST
- Exchange
- RVPHW Nasdaq
- GDST NYSE
- Market Cap
- RVPHW N/A
- GDST N/A
- IPO Year
- RVPHW 2018
- GDST 2022
- Fundamental
- Price
- RVPHW $0.17
- GDST $11.29
- Analyst Decision
- RVPHW
- GDST
- Analyst Count
- RVPHW 0
- GDST 0
- Target Price
- RVPHW N/A
- GDST N/A
- AVG Volume (30 Days)
- RVPHW N/A
- GDST 8.0
- Earning Date
- RVPHW N/A
- GDST 01-01-0001
- Dividend Yield
- RVPHW N/A
- GDST N/A
- EPS Growth
- RVPHW N/A
- GDST 111.15
- EPS
- RVPHW N/A
- GDST 0.23
- Revenue
- RVPHW N/A
- GDST N/A
- Revenue This Year
- RVPHW N/A
- GDST N/A
- Revenue Next Year
- RVPHW N/A
- GDST N/A
- P/E Ratio
- RVPHW N/A
- GDST $49.87
- Revenue Growth
- RVPHW N/A
- GDST N/A
- 52 Week Low
- RVPHW N/A
- GDST $11.29
- 52 Week High
- RVPHW N/A
- GDST $12.45
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- GDST 80.31
- Support Level
- RVPHW N/A
- GDST N/A
- Resistance Level
- RVPHW N/A
- GDST $11.31
- Average True Range (ATR)
- RVPHW 0.00
- GDST 0.00
- MACD
- RVPHW 0.00
- GDST -0.00
- Stochastic Oscillator
- RVPHW 0.00
- GDST 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About GDST GOLDENSTONE ACQUISITION LIMITED
Goldenstone Acquisition Ltd is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.